Laurion Capital Management LP T Scan Therapeutics, Inc. Transaction History

Laurion Capital Management LP

  • $7.27 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$5.85 - $9.51 $1.77 Million - $2.87 Million
-302,084 Reduced 83.34%
60,400 $353,000
Q1 2024

May 15, 2024
BUY
$4.89 - $8.3 $1.48 Million - $2.51 Million
302,084 Added 500.14%
362,484 $2.88 Million
Q4 2023

Feb 14, 2024
BUY
$2.66 - $6.76 $160,664 - $408,304
60,400 New
60,400 $352,000

Others Institutions Holding TCRX

# of Institutions
89
Shares Held
41.8M
Call Options Held
0
Put Options Held
0
View Full List

About TScan Therapeutics, Inc.

TCRX Quotes by TradingView
  • Ticker TCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 18,929,800
  • Market Cap $57.9M
  • Description
  • TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, develops T cell receptor-engineered T cell therapies for the treatment of patients with cancer. It is developing TSC-100 and TSC-101 for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell ...
More about TCRX
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email